The Mission Report


26th Annual
ROTH Conference
March 9-12, 2014 - Ritz-Carlton, Dana Point

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year's annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 17-12. Bringing together executives from more than 400 growth companies, the 26th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit

Presenting Companies: A-E F-J K-O P-T U-Z


KaloBios Pharmaceuticals, Inc. (KBIO)

KaloBios Pharmaceuticals, Inc. (KBIO) is developing a portfolio of proprietary, patient-targeted, first-in-class monoclonal antibodies designed to treat severe life-threatening or debilitating diseases with a clinical focus on severe respiratory diseases and cancer. Currently, KaloBios has three programs in clinical development. All of the company's antibodies were generated using its proprietary Humaneered® technology, a method that converts nonhuman antibodies (typically mouse) into recombinant antibodies that have a high binding affinity to their target and are designed for chronic therapeutic use. For more information, visit the company’s website at

Keryx Biopharmaceuticals, Inc. (KERX)

Keryx Biopharmaceuticals, Inc. (KERX) is focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of renal disease. Keryx is developing ZerenexTM, which has completed a Phase III clinical program for the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis; and has completed a Phase II study for the management of elevated serum phosphorus levels and iron deficiency anemia in patients with Stage 3 to 5 non-dialysis dependent chronic kidney disease. For more information, visit the company’s website at

Kindred Biosciences, Inc. (KIN)

Kindred Biosciences, Inc. (NASDAQ: KIN) is a development-stage biopharmaceutical company focused on providing pets with safe and effective medicines. The company's strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for dogs, cats and horses. Kindred’s lead product candidates are CereKin™ for the treatment of osteoarthritis pain and inflammation in dogs, AtoKin™ for the treatment of atopic dermatitis in dogs, and SentiKin™ for the treatment of post-operative pain in dogs. For more information, visit the company’s website at

Kofax® Limited (KFX)

Kofax® Limited (NASDAQ: KFX) provides smart process applications for the business critical First Mile of customer interactions. These processes provide an essential connection to their systems of record, which are typically large scale, rigid enterprise applications and repositories not easily adapted to more contemporary technology. Kofax software and solutions are used by customers in banking, insurance, government, healthcare, business process outsourcing and other markets. Kofax delivers these through its own sales and service organization, and a global network of more than 800 authorized partners in more than 75 countries. For more information, visit the company’s website at

LabStyle Innovations Corp. (DRIO)

LabStyle Innovations Corp. (OTC: DRIO) develops and commercializes patent-pending technology providing consumers with laboratory-testing capabilities using smart mobile devices. LabStyle's flagship product is the Dario™ Diabetes Management Solution, which has received CE mark certification and began a world rollout in select countries in December 2013. LabStyle filed a Premarket Notification Application with the FDA for the Dario™ smart meter in December 2013. The company is now pursuing patent applications in multiple areas. For more information, visit the company’s website at

La Jolla Pharmaceutical Co. (LJPC)

La Jolla Pharmaceutical Co. (NASDAQ: LJPC) is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics for chronic organ failure and cancer. GCS-100, the Company's lead product candidate, is a first-in-class inhibitor of galectin-3, a novel molecular target implicated in chronic organ failure and cancer. LJPC-501, the company’s second product candidate, is a natural peptide for the treatment of hepatorenal syndrome. For more information, visit the company’s website at

Landec Corp. (LNDC)

Landec Corp. (NASDAQ: LNDC) is a materials science company that leverages its proprietary polymer technologies, application development and innovation capabilities to develop and commercialize new products in food and biomaterials markets. Landec's subsidiary, Apio, has become the leader in US fresh-cut specialty packaged vegetables sold in North America based on combining Landec's proprietary food packaging technology and the strength of two major national brands. For more information, visit the company’s website at

Lannett Co. (LCI)

Lannett Co. Inc. (NYSE: LCI) founded in 1942, develops, manufactures and distributes generic prescription pharmaceutical products in tablet, capsule and oral liquid forms to customers throughout the United States. Lannett markets its products primarily to drug wholesalers, retail drug chains, distributors, and government agencies. The company employs a staff of dedicated people who work together to produce drug products that sick people can afford to buy that will treat their illness, make them well, reduce suffering and improve the quality of their lives. For more information, visit the company’s website at

Lantronix, Inc. (LTRX)

Lantronix, Inc. (NASDAQ: LTRX) is a global leader of secure communication technologies that simplify access and communication with and between virtually any electronic device. The company’s smart M2M (machine-to-machine) and IoT (Internet of Things) connectivity solutions enable sharing data between devices and applications to empower businesses to make better decisions based on real-time information, and gain a competitive advantage by generating new revenue streams, improving productivity and increasing efficiency and profitability. For more information, visit the company’s website at

Lawson Products, Inc. (LAWS)

Lawson Products, Inc. (NASDAQ: LAWS) is an industrial distributor of approximately 300,000 maintenance and repair products. The company serves the industrial, commercial, institutional and government maintenance, repair and operations (MRO) market. The company ships products to customers in all 50 states, Puerto Rico, Canada, Mexico and the Caribbean from five strategically located distribution centers in North America. Under its Kent Automotive brand, Lawson Products supplies products to collision and mechanical repair shops as well as automotive OEMs. For more information, visit the company’s website at

LeapFrog Enterprises, Inc. (LF)

LeapFrog Enterprises, Inc. (NYSE: LF) provides educational entertainment for children. For nearly 20 years, LeapFrog has created award-winning learning solutions that combine educational expertise, innovative technology and a child's love for fun. LeapFrog helps children achieve their potential through LeapFrog's proprietary learning tablets, learn to read and write systems, interactive learning toys and more. LeapFrog's Learning Path, the ultimate guide for parents on early childhood, is designed specifically to help support and guide their child's learning with personalized ideas and feedback, fun activities and expert advice. For more information, visit the company’s website at

LeMaitre Vascular, Inc. (LMAT)

LeMaitre Vascular, Inc. (NASDAQ: LMAT) is a provider of devices for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. LeMaitre, XenoSure, TRIVEX and the LeMaitre Vascular logo are registered trademarks of LeMaitre Vascular, Inc. For more information, visit the company’s website at

LifeVantage Corp. (LFVN)

LifeVantage Corp. (NASDAQ: LFVN), is a science-based network marketing company and the maker of Protandim®, the Nrf2 Synergizer® patented dietary supplement, TrueScience® Anti-Aging Cream and LifeVantage® Canine Health. LifeVantage is dedicated to visionary science that looks to transform wellness and anti-aging internally and externally with products that dramatically reduce oxidative stress at the cellular level. LifeVantage was founded in 2003 and is headquartered in Salt Lake City, Utah. For more information, visit the company’s website at

Ligand Pharmaceuticals, Inc. (LGND)

Ligand Pharmaceuticals, Inc. (NASDAQ: LGND) is a biopharmaceutical company focused on maintaining and growing its large portfolio of revenue generating assets through licensing and acquisition with the goal to optimize and sustain cash-flow and profitability. Ligand has a diverse asset portfolio addressing the unmet medical needs of patients for a broad spectrum of diseases including thrombocytopenia, multiple myeloma, diabetes, hepatitis, muscle wasting, dyslipidemia, anemia and osteoporosis. For more information, visit the company’s website at

Limoneira Company (LMNR)

Limoneira (NASDAQ: LMNR), a 120-year-old international agribusiness headquartered in Santa Paula, California, has grown to become one of the premier integrated agribusinesses in the world. Limoneira (pronounced lē mon΄âra) is a dedicated sustainability company with approximately 10,000 acres of rich agricultural lands, real estate properties and water rights in California and Arizona. The Company is a leading producer of lemons, avocados, oranges, specialty citrus and other crops that are enjoyed throughout the world. For more information, visit the company’s website at

Lion Biotechnologies, Inc. (LBIO)

Lion Biotechnologies, Inc. (OTC: LBIO) is engaged in the development of T-cells and engineered T-cells for the treatment of various cancers. The company's lead product candidate is a ready-to-infuse autologous T-cell therapy utilizing tumor-infiltrating lymphocytes (TILs) for the treatment of patients with Stage IV metastatic melanoma, and is based on a clinical CRADA with the National Cancer Institute along with physician-sponsored investigational therapy at the MD Anderson Cancer Center and the H. Lee Moffitt Cancer & Research Institute. For more information, visit the company’s website at

Lionbridge Technologies, Inc. (LIOX)

Lionbridge Technologies, Inc. (NASDAQ: LIOX) enables more than 800 brands to increase international market share, speed adoption of products, and reach their customers in local markets worldwide. Using the company’s innovative cloud technology platforms and more than 100,000 professional cloud workers, Lionbridge provides translation, online marketing, global content management and application testing solutions that contribute to global brand consistency, local relevancy and technical usability across all touch points of the customer lifecycle. Based in Waltham, Mass., Lionbridge presides in 26 countries. For more information, visit the company’s website at

Lipocine, Inc. (LPCN)

Lipocine, Inc. (OTC: LPCN) is a specialty pharmaceutical company developing innovative pharmaceutical products for use in men's and women's health using its proprietary drug delivery technologies. Lipocine's lead product candidate, LPCN 1021, is Phase III ready and is targeted to treat symptoms of low testosterone for men in need of testosterone replacement therapy. Additional pipeline candidates include LPCN 1111, a next generation oral testosterone therapy product, and LPCN 1107, which has the potential to become the first oral hydroxyprogesterone caproate product indicated for the prevention of preterm birth. For more information, visit the company’s website at

Liquid Holdings Group, Inc. (LIQD)

Liquid Holdings Group, Inc. (NASDAQ: LIQD) is a cloud-based technology and managed services provider that targets global hedge fund and active trading markets. Liquid's solutions are delivered through the cloud in a SaaS model. The Liquid platform was built to manage the entire trade lifecycle by integrating multi-currency, multi-asset trade order management and execution with real-time risk, portfolio management, and shadow account reporting through a single solution. Founded in 2012, the company is headquartered in New York, New York. For more information, visit the company’s website at

Liquidity Services, Inc. (LQDT)

Liquidity Services, Inc. (NASDAQ: LQDT) provides leading corporations, public sector agencies, and buying customers the world's most transparent, innovative, and effective online marketplaces and integrated services for surplus assets. On behalf of its clients, Liquidity Services has completed the sale of over $4.4 billion of surplus, returned, and end-of-life assets in over 500 product categories, including consumer goods, capital assets, and industrial equipment. The company is based in Washington, D.C. and has more than 1,300 employees. For more information, visit the company’s website at

LivePerson, Inc. (LPSN)

LivePerson, Inc. (NASDAQ: LPSN) offers a cloud-based platform that enables businesses to proactively connect in real-time with their customers via chat, voice, and content delivery at the right time, through the right channel, including websites, social media, and mobile devices. This "intelligent engagement" is driven by real-time behavioral analytics, producing connections based on a true understanding of business objectives and customer needs. For more information, visit the company’s website at

Local Corp. (LOCM)

Local Corp. (NASDAQ: LOCM) is a local advertising and technology company that connects businesses with approximately a million online and mobile consumers each day using a variety of innovative digital advertising products. The company’s consumer properties include the flagship site and a network of approximately 1,600 partner sites. With a powerful combination of patented technologies, unique products, a scalable platform and an extensive partner network, Local has been a Deloitte Fast 500 company for four years in a row. For more information, visit the company’s website at

Lorus Therapeutics, Inc. (LRUSF)

Lorus Therapeutics, Inc. (OTC: LRUSF, LOR.TO) is a biopharmaceutical company targeting essential apoptosis pathways to deliver transformational cancer drugs. The company’s goal is to capitalize on its research, preclinical, clinical and regulatory expertise by developing new drug candidates that can be used alone and in combination with other drugs to successfully treat specific forms of cancer. Through its own discovery efforts, as well as partnering activities, Lorus is building a portfolio of promising anticancer drugs ranging from discovery and preclinical to clinical-proof-of concept stage. For more information, visit the company’s website at

Lpath, Inc. (LPTN)

Lpath, Inc. (NASDAQ: LPTN), an antibody-platform company, is the category leader in lipid-targeted therapeutics. The company's ImmuneY2™ drug-discovery engine has the unique ability to generate therapeutic antibodies that bind to and inhibit bioactive lipids that contribute to disease. With this platform, the company has developed four drug candidates, two of which—iSONEP for wet AMD and ASONEP for cancer—are currently being investigated in Phase 2 trials. Lpath is also developing other candidates such as an anti-leukotriene antibody, Altepan™, which is being studied in models of respiratory disease. For more information, visit the company’s website at


LRAD Corp. (NASDAQ: LRAD) is using long range communication to peacefully resolve uncertain situations and save lives on both sides of its proprietary Long Range Acoustic Device®. LRAD® systems are in service in more than 65 countries around the world in diverse applications including fixed and mobile military deployments, maritime security, critical infrastructure and perimeter security, commercial security, border and port security, law enforcement and emergency responder communications, emergency warning and mass notification, asset protection and wildlife preservation and control. For more information, visit the company’s website at

MacroGenics, Inc. (MGNX)

MacroGenics, Inc. (NASDAQ: MGNX) is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. The company’s product pipeline candidates are derived from its proprietary suite of next-generation antibody technology platforms, which it believes improve the performance of monoclonal antibodies and antibody-derived molecules. The company creates both differentiated molecules that are directed to novel cancer targets, as well as "bio-betters," which are drugs designed to improve upon marketed medicines. For more information, visit the company’s website at

Mad Catz Interactive, Inc. (MCZ)

Mad Catz Interactive, Inc. (NYSE: MCZ) is a global provider of innovative interactive entertainment products marketed under its Mad Catz® (gaming), Tritton® (audio), and Saitek® (simulation) brands. Mad Catz products cater to passionate gamers across multiple platforms including in-home gaming consoles, handheld gaming consoles, Windows® PC and Mac® computers, smart phones, tablets and other mobile devices. Mad Catz distributes its products through its online store as well as distribution via many leading retailers around the globe. For more information, visit the company’s website at

Magellan Petroleum Corp. (MPET)

Magellan Petroleum Corp. (NASDAQ: MPET) is an independent oil and gas exploration and development company with assets in the US, Australia, and the UK. The Company is primarily focused on the development of a CO2-enhanced oil recovery ("CO2-EOR") program at Poplar Dome in eastern Montana. Historically active in Australia, Magellan operates two gas field’s onshore Northern Territory and an exploration block in the Bonaparte Basin, offshore Northern Territory. For more information, visit the company’s website at

MAMS Software Group, Inc. (MAMS)

MAMS Software Group, Inc. (NASDAQ: MAMS), through its subsidiaries, provides business and ERP supply chain management solutions for automotive parts manufacturers, distributors and retailers. The company supplies the automotive aftermarket with a combination of business management systems, information products, and online services that together deliver benefits for all parties involved in vehicle repair. For more information, visit the company’s website at

Manitex International, Inc. (MNTX)

Manitex International, Inc. (NASDAQ: MNTX) designs, manufactures and markets a portfolio of highly engineered and customizable lifting, material and container handling equipment, spanning boom truck, telescopic, rough terrain and industrial cranes, reach stackers and associated container handling equipment, rough terrain forklifts, mobile liquid and solid containment solutions, and specialized trailers and mission oriented vehicles, including parts support. The company has accumulated nearly a dozen brands since going public in 2006 and operates internationally through eight subsidiaries in the U.S.A, Canada and Italy. For more information, visit the company’s website at

Marathon Patent Group (MARA)

Marathon Patent Group (OTC: MARA) is a patent acquisition and licensing company that acquires patents from a wide range of patent holders from individual inventors to Fortune 500 companies. The company’s strategy of acquiring patents that cover a wide-range of subject matter allows us to achieve diversity within our patent asset portfolio. Marathon Patent Group monetizes its diversified portfolio through actively managed concurrent licensing campaigns. This approach is expected to result in a long-term, diversified revenue stream. For more information, visit the company’s website at

Marrone Bio Innovations, Inc. (MBII)

Marrone Bio Innovations, Inc. (NASDAQ: MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental, and water treatment markets. Their effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. MBII has a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. For more information, visit the company’s website at

Masimo Corp. (MASI)

Masimo Corp. (NASDAQ: MASI) is the global leader in innovative noninvasive monitoring technologies that significantly improve patient care-helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through Motion and Low Perfusion pulse oximetry, known as Masimo SET®, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent studies have shown that Masimo SET® outperforms other pulse oximetry technologies. For more information, visit the company’s website at

MaxLinear, Inc. (MXL)

MaxLinear, Inc. (MXL) MaxLinear is a provider of highly integrated radio-frequency analog and mixed signal semiconductor SoC solutions for broadband communications applications offering high levels of performance, small silicon die-size, and low power consumption. MaxLinear's products enable the reception of broadband data and video content in a wide range of electronic devices, including cable and terrestrial set-top boxes, DOCSIS voice and data cable modems, digital televisions, personal computers, netbooks and in-vehicle entertainment devices. For more information, visit the company’s website at

Maxwell Technologies, Inc. (MXWL)

Maxwell Technologies, Inc. (NASDAQ: MXWL) is a global leader in the development and manufacture of innovative, cost-effective energy storage and power delivery solutions. Its ultracapacitor products provide safe and reliable power solutions for applications in consumer and industrial electronics, transportation and telecommunications. The company’s CONDIS® high-voltage grading and coupling capacitors help ensure the safety and reliability of electric utility infrastructure and other applications involving transport, distribution and measurement of high-voltage electrical energy. For more information, visit the company’s website at

McEwen Mining, Inc. (MUX)

McEwen Mining, Inc. (NYSE: MUX) is a growing gold and silver producer in the Americas. The company’s principal assets consist of a 49% interest in Minera Santa Cruz SA, owner of the San José silver-gold mine in Argentina, and Phase I of the El Gallo complex in Sinaloa, Mexico; Phase II of the El Gallo complex in Sinaloa, Mexico, The Gold Bar project in Nevada, and the Los Azules copper deposit in San Juan, Argentina; and a large portfolio of exploration properties in Santa Cruz province Argentina. For more information, visit the company’s website at

MediGus Ltd. (MDGS)

MediGus Ltd. (TASE: MDGS) is leading the transition from invasive gastric surgery procedures to less invasive, patient-friendly techniques through the development of minimally invasive endoscopic devices and procedures. The company's revolutionary MUSE™ system enables endoscopists to treat gastroesophageal reflux disease (GERD), a chronic disease with increasing global prevalence, by performing a fundoplication procedure through the mouth. For more information, visit the company’s website at

Medgenics, Inc. (MDGN)

Medgenics, Inc. (MDGN) is developing and commercializing Biopum™, a proprietary platform for the sustained production and delivery of therapeutic proteins using ex-vivo gene therapy and the patient's own tissue for the treatment of orphan and rare diseases. Medgenics believes that this biological approach can replace a major portion of the regular and costly injections of therapeutic proteins patients currently receive. Beyond this, the Company plans to develop a pipeline of products based on its Biopump technology targeting the large and rapidly growing global protein therapy market. For more information, visit the company's website at

MeetMe® (MEET)

MeetMe® (NYSE: MEET) is a social network for meeting new people in the U.S. and the public market leader for social discovery. MeetMe connects people through social games and apps, monetized by both advertising and virtual currency. With 60 percent of traffic coming from mobile, MeetMe is fast becoming the social gathering place for the mobile generation. The company operates and MeetMe apps on iPhone, iPad, and Android in multiple languages including English, Spanish, Portuguese, French, Italian, German, Russian, Japanese, Dutch, Turkish and Korean. For more information, visit the company’s website at

MEI Pharma, Inc. (MEIP)

MEI Pharma, Inc. (NSADAQ: MEIP) is an oncology company focused on the clinical development of novel therapies for cancer. The Company's lead drug candidate is Pracinostat, a potential, oral HDAC inhibitor currently being developed for myelodysplastic syndrome (MDS) and AML. Results from a pilot Phase II clinical trial of Pracinostat in combination with Vidaza in patients with advanced MDS showed an overall response rate of 90% (nine of 10). Data from three ongoing Phase II clinical trials of Pracinostat are expected by the end of 2014. For more information, visit the company’s website at

Metabolix, Inc. (MBLX)

Metabolix, Inc. (NASDAQ: MBLX) is an advanced biomaterials company delivering sustainable solutions to the plastics, chemicals and energy industries. The company is developing high-performance biopolymers targeted to the markets for film and bag applications, performance additives and functional biodegradation. Metabolix's bio-based chemicals platform is focused on high-value segments and applications using its novel "FAST" recovery process. Metabolix is also developing a platform for co-producing plastics, chemicals and energy from crops. For more information, visit the company’s website at

MetaStat, Inc. (MTST)

MetaStat, Inc. (OTC: MTST) is a life sciences company that develops and commercializes diagnostic products and novel therapeutics for the early and reliable prediction and treatment of systemic metastasis. MetaStat is focused on breast, prostate, lung and colorectal cancers. Both the MetaSite Breast™ and MenaCalc™ product lines are designed to accurately stratify patients based on their individual risk of metastasis. The MenaBloc™ therapeutic program aims to build upon mena biology and alternative splicing events as a driver of disease progression to exploit novel targets that provide precision medicines in oncology. For more information, visit the company's website at

Micron Technology, Inc. (MU)

Micron Technology, Inc. (NASDAQ: MU) is a global leader in advanced semiconductor systems. Micron's broad portfolio of high-performance memory technologies—including DRAM, NAND and NOR Flash—is the basis for solid state drives, modules, multichip packages and other system solutions. Backed by more than 35 years of technology leadership, Micron's memory solutions aids in the functioning of the world's most innovative computing, consumer, enterprise storage, networking, mobile, embedded and automotive applications. For more information, visit the company’s website at

Microsemi Corp. (MSCC)

Microsemi Corp. (NASDAQ: MSCC) offers a comprehensive portfolio of semiconductor and system solutions for communications, defense & security, aerospace and industrial markets. Products include high-performance and radiation-hardened analog mixed-signal integrated circuits, FPGAs, SoCs and ASICs; power management products; timing and synchronization devices and precise time solutions, setting the world's standard for time; voice processing devices; RF solutions; discrete components; security technologies and scalable anti-tamper products; Power-over-Ethernet ICs and midspans; as well as custom design capabilities and services. For more information, visit the company’s website at

MicroVision, Inc. (MVIS)

MicroVision, Inc. (NASDAQ: MVIS) is the creator of PicoP® display technology, an ultra-miniature laser projection solution for mobile consumer electronics, automotive head-up displays and other applications. The company’s patented display technology helps OEMs break down display boundaries and offer enhanced visibility to mobile experiences. Nearly two decades of research has led MicroVision to become an independently recognized leader in the development of intellectual property. For more information, visit the company’s website at

Middleby Corp. (MIDD)

Middleby Corp. (NASDAQ: MIDD) operates within the foodservice equipment industry. The company develops, manufactures, markets and services a broad line of equipment used in the commercial foodservice, food processing, and residential kitchen equipment industries. Its equipment brands serve the commercial foodservice industry with Anets®, Beech®, Blodgett®, Blodgett Combi®, Blodgett Range®, Bloomfield®, Britannia®, Carter-Hoffmann®, Celfrost®, CookTek®, CTX®, Doyon®, frifri®, Giga®, Holman®, Houno®, IMC®, Jade®, Lang®, Lincat®, MagiKitch'n®, Market Forge®,Middleby Marshall®, MPC©, Nieco®, Nu-Vu®, PerfectFry®, Pitco Frialator®, Southbend®, Star®, Toastmaster®, TurboChef®, Viking®, Wells® and Wunder-Bar®. For more information, visit the company’s website at

Montage Technology Group Ltd. (MONT)

Montage Technology Group Limited (NASDAQ: MONT) is a global leading fabless provider of analog and mixed-signal semiconductor solutions currently addressing the home entertainment and cloud computing markets. The foundation of company's technology platform is the ability to design high performance, low power semiconductors by using the proprietary building blocks which include radio frequency and analog front end solutions, digital signal processors and high speed interfaces. For more information, visit the company’s website at

MoSys, Inc. (MOSY)

MoSys, Inc. (NASDAQ: MOSY) is a fabless semiconductor company enabling leading equipment manufacturers in the networking and communications systems markets to address the continual increase in Internet users, data and services. The company's solutions deliver data path connectivity, speed and intelligence while eliminating data access bottlenecks on line cards and systems scaling from 100G to multi-terabits per second. MoSys is headquartered in Santa Clara, California. For more information, visit the company’s website at

Motocar Parts of America, Inc. (MPAA)

Motorcar Parts of America, Inc. (NASDAQ: MPAA) is a remanufacturer, manufacturer and distributor of automotive aftermarket parts -- including alternators, starters and wheel hub assembly products utilized in imported and domestic passenger vehicles, light trucks and heavy duty applications. Motorcar Parts of America's products are sold to automotive retail outlets and the professional repair market throughout the United States and Canada, with remanufacturing facilities located in California, Mexico and Malaysia, and administrative offices located in California, Tennessee, Mexico, Singapore and Malaysia. For more information, visit the company’s website at

Multimedia Games Holding Company, Inc. (MGAM)

Multimedia Games Holding Company, Inc. (NASDAQ: MGAM) develops and distributes gaming technology, and is a creator and supplier of comprehensive systems, content and electronic gaming units for Native American and commercial casinos. Revenue is primarily derived from gaming units in operation on revenue-sharing arrangements. The company also offers and generates revenue from the sale of gaming units and systems that feature proprietary game content and game themes licensed from others. The company is focused on pursuing market expansion and new product development for commercial and tribal casinos and VLT markets. For more information, visit the company’s website at

Nanosphere, Inc. (NSPH)

Nanosphere, Inc. (NASDAQ: NSPH) is enhancing medicine through targeted molecular diagnostics that result in earlier disease detection, optimal patient treatment and improved healthcare economics. The Company's versatile technology platform, the Verigene(R) System, enables clinicians to rapidly detect the most complex, costly and deadly infectious diseases through a low cost and simple-to-use multiplexed diagnostic test. The combination of this innovative technology and Nanosphere's customer-driven solutions keeps commitment to the patient at the forefront of its business. For more information, visit the company’s website at

Nanoviricides, Inc. (NNVC)

Nanoviricides, Inc. (NYSE: NNVC) is a development stage company that is creating special purpose nanomaterials for viral therapy. The company's nanoviricide® class of drug candidates are designed to attack enveloped virus particles and to dismantle them. The company is developing drugs against a number of viral diseases, including H1N1 swine flu, H5N1 bird flu, seasonal influenza, HIV, oral and genital herpes, viral diseases of the eye (including EKC and herpes keratitis), hepatitis C, rabies, dengue fever, and Ebola virus, among others. For more information, visit the company’s website at

NAPCO Security Technologies, Inc. (NSSC)

NAPCO Security Technologies, Inc. (NASDAQ: NSSC) is a global manufacturer of technologically advanced electronic security equipment including intrusion and fire alarm systems, access control and door locking systems. The company, which consists of NAPCO and its subsidiaries Alarm Lock, Continental Instruments, and Marks USA, offers products that are installed by security professionals worldwide in commercial, industrial, institutional, residential and government applications. For more information, visit the company’s website at

Natus Medical, Inc. (BABY)

Natus Medical Inc., (BABY) founded in 1989, is a manufacturer of medical devices and software and a service provider for the Newborn Care, Neurology, Sleep, Hearing and Balance markets. Natus products are used in hospitals, clinics and laboratories worldwide. The mission is to improve outcomes and patient care in target markets through innovative screening, diagnostic and treatment solutions. Products manufactured by Natus are sold through a combination of a direct sales force and worldwide distribution partners. For more information, visit the company’s website at

Nektar Therapeutics (NKTR)

Nektar Therapeutics (NASDAQ: NKTR) is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms. Nektar has a robust R&D pipeline of potentially high-value therapeutics in oncology, pain and other therapeutic areas. Nektar's technology has enabled eight approved products in the U.S. or Europe through partnerships with leading biopharmaceutical companies, including UCB's Cimzia® for Crohn's disease and rheumatoid arthritis, Roche's PEGASYS® for hepatitis C, and Amgen's Neulasta® for neutropenia. For more information, visit the company’s website at

Neogen Corp. (NEOG)

Neogen Corp. (NEOG) develops and markets products dedicated to food and animal safety. Neogen's animal genomics businesses, GeneSeek and Igenity, provide services to agricultural genetics providers, large national cattle associations, companion animal breed registries, university researchers, and numerous commercial cattle producers. The company headquarters are located in Lansing, Michigan, with several U.S. based offices possessing ISO 9001 certified quality management systems. In January 2014 the company announced it licensed patents owned by Cargill, Inc. and Branhaven LLC. For more information, visit the company’s website at

Neptune Technologies & Bioresources, Inc. (NEPT)

Neptune Technologies & Bioresources, Inc. (NASDAQ: NEPT) is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids (''PUFAs''). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune's distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. The company’s products include NKO®, EKO™ and NKA™ – Krill Protein. For more information, visit the company’s website at

NetDimensions Holdings Ltd. (NETDY)

NetDimensions Holdings Ltd. (OTC: NETDY) provides talent management solutions to companies, government agencies and other organizations. The company’s solutions allow organizations to personalize learning, share knowledge, enhance performance, foster collaboration, and manage compliance programs for their employees, customers, partners and suppliers. The company is recognized as a top-rated technology supplier for the talent management industry and has served several leading global organizations including ING, Cathay Pacific, Hunter Douglas, and the Chicago Police Department. For more information, visit the company’s website at

Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences Inc. (NBIX) of San Diego discovers and develops pharmaceuticals, in diseases with high unmet medical needs, through its novel R&D platform, focused on neurological and endocrine based diseases and disorders. The company's two lead late-stage clinical programs are elagolix, a gonadotropin-releasing hormone antagonist for women's health that is partnered with AbbVie Inc., and a wholly owned vesicular monoamine transporter 2 inhibitor for the treatment of movement disorders. For more information, visit the company’s website at

Nuverra Environmental Solutions, Inc. (NES)

Nuverra Environmental Solutions (NES) is dedicated to providing comprehensive and full-cycle environmental solutions to customers in energy and industrial end-markets. Nuverra focuses on the delivery, collection, treatment, recycling, and disposal of restricted solids, water, wastewater, used motor oil, spent antifreeze, waste fluids and hydrocarbons. The company continues to expand its suite of sustainable solutions to customers who demand stricter environmental compliance and accountability from their service providers. For more information, visit the company’s website at

Newport Corp. (NEWP)

Newport Corp. (NASDAQ: NEWP) is a global supplier of advanced-technology products and systems for the scientific research, aerospace and defense/security, microelectronics, life and health sciences and precision industrial manufacturing markets. Newport's solutions leverage its expertise in photonics technologies, including lasers, photonics instrumentation, sub-micron positioning systems, vibration isolation, optical components and subsystems, precision automation, productivity of its customers' manufacturing, engineering and research applications, and more. For more information, visit the company’s website at

Nova Measuring Instruments Ltd. (NVMI)

Nova Measuring Instruments Ltd. (NASDAQ: NVMI) develops, produces and markets advanced integrated and stand-alone metrology solutions for the semiconductor manufacturing industry. The company’s suite of technological capabilities includes broadband spectrophotometry, scatterometry and imaging and image processing. Products include metrology systems, optical CD and Metal Line Thickness (MLT) systems, and optical critical dimension systems. For more information, visit the company’s website at

NTN Buzztime, Inc. (NTN)

NTN Buzztime, Inc. (NYSE: NTN) is a bar and restaurant social entertainment and integrated marketing platform. The company’s technology is used in more than 3,200 bars and restaurants in North America. Buzztime integrates trivia, card and sports games with in- and out-of-venue messaging and communication tools. The company has more than 4.2 million player registrations on the Buzztime platform and more than 52 million games played each year. For more information, visit the company’s website at

NV5 Holdings, Inc. (NVEE)

NV5 Holdings, Inc. (NVEE) is a provider of professional and technical engineering and consulting solutions to public and private sector clients in the infrastructure, energy, construction, real estate and environmental markets. NV5 focuses on five business service verticals: construction quality assurance, infrastructure engineering, energy services, program management and environmental services. The company operates 22 offices in California, Colorado, Utah, Florida and New Jersey and is headquartered in Hollywood, Florida. For more information, visit the company’s website at

Odyssey Marine Exploration, Inc. (OMEX)

Odyssey Marine Exploration, Inc. (NASDAQ: OMEX) engages in the archaeologically sensitive exploration and recovery of deep-ocean shipwrecks worldwide. The company’s shipwreck projects consist of various activities, including research operations for historical records and academic materials; search operations; archaeological excavation and recovery operations; and conservation, recording and documentation. It also sells coins, bullion and other mass-produced cargo, as well as cultural collections and replicas to collectors, museums and other institutions. For more information, visit the company’s website at

Ohr Pharmaceutical, Inc. (OHRP)

Ohr Pharmaceutical Inc. (OHRP) is a pharmaceutical company committed to the clinical development of new drugs for underserved therapeutic needs in large and growing markets. The company is focused on advancing its pipeline products currently in phase II clinical development: Squalamine Eye Drops for the treatment of the wet form of age-related macular degeneration, and OHR/AVR118 for the treatment of cancer cachexia. Rounding out the company’s pipeline candidates is Trodusquemine, a selective, non-competitive inhibitor of the enzyme protein tyrosine phosphatase 1B (PTB1B). For more information, visit the company’s website at

On Assignment, Inc. (ASGN)

On Assignment Inc. (ASGN) is a provider of in-demand, skilled professionals in the technology, healthcare, and life sciences sectors. Company services extend beyond traditional resume matching with job descriptions to connect people with positions they understand for temporary, contract-to-hire, and direct hire assignments. The company is recognized for their quality candidates and quick responses. On Assignment positions itself as a career-building partner with the depth and breadth of experience to help their clients reach their goals. For more information, visit the company’s website at

On Track Innovations Ltd. (OTIV)

On Track Innovations Ltd. (NASDAQ: OTIV) provides contactless and NFC applications based on its extensive patent and IP portfolio. The company’s field-proven innovations have been deployed around the world to address NFC payment solutions, petroleum payment and management, cashless parking fee collection systems and mass transit ticketing. On Track Innovations markets and supports its solutions through a global network of regional offices and alliances. For more information, visit the company’s website at

Oramed, Inc. (ORMP)

Oramed (ORMP) a technology company in the field of oral delivery solutions for drugs and vaccines currently delivered via injection. Established in 2006, Oramed's Protein Oral Delivery (POD™) technology is based on over 30 years of research by research scientists at Jerusalem's Hadassah Medical Center. Oramed is seeking to enhance the treatment of diabetes through its proprietary flagship product, an orally ingestible insulin capsule (ORMD-0801), is currently in Phase 2 clinical trials on patients with type 2 diabetes (T2DM). For more information, visit the company’s website at

Orion Energy Systems Inc. (OESX)

Orion Energy Systems Inc. (OESX) is a power technology enterprise that designs, manufactures and deploys energy management systems primarily consisting of energy-efficient lighting platforms, intelligent wireless control systems and direct renewable solar technology for commercial and industrial customers – all implemented without compromising the quantity and quality of light. The company’s technology focusses on lighting, controls, daylighting and rooftop solar photovoltaic systems for stable economic returns on invested capital or free cash flow from power purchase agreements. For more information, visit the company’s website at

Ormat Technologies, Inc. (ORA)

Ormat Technologies, Inc. (NYSE: ORA) owns, operates, designs, manufactures and sells geothermal and REG power plants primarily based on the Ormat Energy Converter—a power generation unit that converts heat into electricity. Ormat has more than 82 U.S. patents. The company has engineered, manufactured and constructed power plants, which it currently owns or has supplied to utilities and developers worldwide, totaling over 1750 MW of gross capacity. Ormat's current generating portfolio is spread globally in the U.S., Guatemala and Kenya. For more information, visit the company’s website at

Osage Exploration and Development, Inc. (OEDV)

Osage Exploration and Development, Inc. (OTC: OEDV) is an independent exploration and production company concentrating on the Horizontal Mississippian and Woodford plays in Oklahoma. It engages mainly in the acquisition, development, production, and sale of oil, gas, and natural gas liquids. The company presently owns a pipeline with a capacity of approximately 40,000 barrels of oil per day, as well as a 9.4% interest in oil and gas assets in the Guaduas field located in the Dindal. For more information, visit the company’s website at

OSI Systems, Inc. (OSIS)

OSI Systems, Inc. (OSIS) is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications. The company sells its products worldwide into diversified markets, including homeland security, healthcare, defense and aerospace. OSI operating divisions include Rapiscan Systems focused on security and inspection solutions, Spacelabs Healthcare which designs and markets patient monitoring, diagnostic cardiology and anesthesia systems and OSI Optoelectronics, a developer and manufacturer of optoelectronic devices and value-added manufacturing services. For more information, visit the company’s website at

OvaScience (OVAS)

OvaScience (OVAS) is a life sciences company focused on the discovery, development and commercialization of new fertility treatments. The company’s patented technology is based on the discovery of egg precursor cells (EggPCSM), which are found in the ovaries. By applying the company’s proprietary technology applications to identify and purify EggPCs, OvaScience is developing potential next generation in vitro fertilization (IVF) treatments. OVAS currently has three fertility treatments in development: AUGMENTSM, OvaPrimeSM and OvaTureSM, which seeks to create mature fertilizable eggs from a woman’s own EggPCs without the need for hormone injections. For more information, visit the company’s website at

Overland Storage, Inc. (OVRL)

Overland Storage Inc. (OVRL) is a global provider of unified data management and data protection solutions across the data lifecycle. By providing an integrated range of technologies for primary, nearline, offline, and archival data storage, Overland assists with the management of different tiers of information over time regardless of distance. Overland SnapServer, RDX removable disk-based technology, SnapScale, SnapServer, SnapSAN, NEO Series and REO Series solutions are available through resellers and system integrators. This channel model is supported by OEM agreements with major manufacturers. For more information, visit the company’s website at


OXiGENE, Inc. (OXGN) is a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer. The company's major focus is developing vascular disrupting agents (VDAs) that selectively disrupt abnormal blood vessels associated with solid tumor progression. OXiGENE is dedicated to leveraging its intellectual property and therapeutic development expertise to bring life-extending and life-enhancing medicines to patients. For more information, visit the company’s website at


For more frequent updates, follow us on Twitter!

Home     About Us     Blog     Investors     IR Services     Market Research     Partners     Contact     Disclaimer

© 2014 Mission Investor Relations. All rights reserved.
3645 Marketplace Blvd.   Suite 130-280   Atlanta, GA 30344   404-941-8975